Lemaitre Vascular Inc
LMAT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001158895
No open-market purchases or sales by Lemaitre Vascular Inc insiders were filed in the last 90 days; 327 institutions reported holding it in 13F filings for Q2 2026, worth $2.20B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Lemaitre Vascular Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 307
- +18 vs. Q3 2024
- Shares held
- 21.2M
- +356.4K (+1.7%) vs. Q3 2024
- Total value
- $1.95B
- +$17.5M (+0.9%) vs. Q3 2024
- New holders
- 43
- 123 more added
- Sold out
- 25
- 96 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LMAT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 327 | $2.20B |
| Q1 2026 | 341 | $2.42B |
| Q4 2025 | 297 | $1.73B |
| Q3 2025 | 297 | $1.84B |
| Q2 2025 | 283 | $1.76B |
| Q1 2025 | 288 | $1.77B |
| Q4 2024 | 307 | $1.95B |
| Q3 2024 | 291 | $1.95B |
| Q2 2024 | 262 | $1.69B |
| Q1 2024 | 243 | $1.34B |
| Q4 2023 | 227 | $1.14B |
| Q3 2023 | 220 | $1.06B |
| Q2 2023 | 212 | $1.27B |
| Q1 2023 | 185 | $968.0M |
| Q4 2022 | 182 | $876.0M |
| Q3 2022 | 189 | $969.5M |
| Q2 2022 | 180 | $879.0M |
| Q1 2022 | 183 | $872.4M |
| Q4 2021 | 182 | $924.8M |
| Q3 2021 | 195 | $989.0M |
| Q2 2021 | 185 | $1.08B |
| Q1 2021 | 179 | $875.5M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Lemaitre Vascular Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Congress Asset Management Co | 722,325 | $66.6M | 0.45% | +13,009+1.8% | Added |
| State Street Corp | 843,744 | $77.7M | 0.00% | +21,659+2.6% | Added |
| Geneva Capital Management LLC | 865,582 | $79.8M | 1.38% | −12,263−1.4% | Reduced |
| Copeland Capital Management, LLC | 1,172,015 | $108.0M | 2.01% | +8,623+0.7% | Added |
| Vanguard Group Inc | 1,580,117 | $145.6M | 0.00% | +1,846+0.1% | Added |
| Conestoga Capital Advisors, LLC | 1,692,834 | $156.0M | 2.07% | −285,517−14.4% | Reduced |
| BlackRock, Inc. | 3,913,832 | $360.6M | 0.01% | +236,959+6.4% | Added |
| Norges Bank | 0 | $0 | 0.00% | −98,278−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,928−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −6,417−100.0% | Sold out |
| Summit Global Investments | 0 | $0 | 0.00% | −6,192−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −5,701−100.0% | Sold out |
| Everence Capital Management Inc | 0 | $0 | 0.00% | −5,530−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −5,257−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −4,472−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,279−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −3,705−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −3,472−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −3,020−100.0% | Sold out |
| Keebeck Alpha, LP | 0 | $0 | 0.00% | −2,690−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −2,368−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −2,338−100.0% | Sold out |
| James Investment Research Inc | 0 | $0 | 0.00% | −2,165−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −433−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −137−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Financial Network Wealth Advisors LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Scout Investments, Inc. | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |